IBM's AI classifies seizure types to help people with epilepsy

About 1.2 percent of people in the U.S. -- and 3.4 million worldwide -- have active epilepsy, and roughly one in 26 people will develop it in their lifetime. Not all suffer seizures the same -- and for a third of patients, no medical treatment options exist. As for the remaining two thirds, the available treatments don't always behave predictably, owing to the condition's individualized nature. Lack of measurement is a long-standing barrier to better outcomes. Studies show that one common source of data -- written diaries -- tends to be only 50 percent accurate.